- Home
- CARE vs CRVS Comparison
CARE vs CRVS Comparison
Compare CARE & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARE
- CRVS
- Stock Information
- Founded
- CARE 1974
- CRVS 2014
- Country
- CARE United States
- CRVS United States
- Employees
- CARE N/A
- CRVS N/A
- Industry
- CARE Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- CARE Finance
- CRVS Health Care
- Exchange
- CARE Nasdaq
- CRVS Nasdaq
- Market Cap
- CARE 453.4M
- CRVS 451.0M
- IPO Year
- CARE N/A
- CRVS 2016
- Fundamental
- Price
- CARE $19.37
- CRVS $8.80
- Analyst Decision
- CARE Buy
- CRVS Buy
- Analyst Count
- CARE 2
- CRVS 4
- Target Price
- CARE $21.50
- CRVS $10.83
- AVG Volume (30 Days)
- CARE 60.8K
- CRVS 1.0M
- Earning Date
- CARE 10-24-2024
- CRVS 11-12-2024
- Dividend Yield
- CARE N/A
- CRVS N/A
- EPS Growth
- CARE N/A
- CRVS N/A
- EPS
- CARE 0.62
- CRVS N/A
- Revenue
- CARE $128,505,000.00
- CRVS N/A
- Revenue This Year
- CARE N/A
- CRVS N/A
- Revenue Next Year
- CARE $20.03
- CRVS N/A
- P/E Ratio
- CARE $32.12
- CRVS N/A
- Revenue Growth
- CARE N/A
- CRVS N/A
- 52 Week Low
- CARE $10.95
- CRVS $1.23
- 52 Week High
- CARE $20.37
- CRVS $9.70
- Technical
- Relative Strength Index (RSI)
- CARE 62.09
- CRVS 70.45
- Support Level
- CARE $17.74
- CRVS $7.91
- Resistance Level
- CARE $20.37
- CRVS $9.70
- Average True Range (ATR)
- CARE 0.56
- CRVS 0.75
- MACD
- CARE 0.07
- CRVS -0.01
- Stochastic Oscillator
- CARE 61.98
- CRVS 67.51
About CARE Carter Bankshares Inc.
Carter Bankshares Inc is a bank holding company that conducts its business solely through the bank. The Bank earns revenue from interest on loans and securities and fees charged for financial services provided to customers. The Bank offers a full range of deposit services including Lifetime Free Checking, interest checking accounts, savings accounts, retirement accounts and other deposit accounts of various types, ranging from money market accounts to longer-term CDs. The Bank offers a full range of commercial and consumer loans. The Bank also originates and holds fixed and variable-rate mortgage loans and offers home equity lines of credit to its customers.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers, and autoimmune diseases. The company's primary product candidate is Soquelitinib (CPI-818), an oral, small-molecule drug that selectively inhibits ITK (interleukin-2-inducible T cell kinase). The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).